rs72466496

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004082.5(DCTN1):​c.3746C>T​(p.Thr1249Ile) variant causes a missense change. The variant allele was found at a frequency of 0.00473 in 1,614,110 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0028 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0049 ( 29 hom. )

Consequence

DCTN1
NM_004082.5 missense

Scores

1
5
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:11O:1

Conservation

PhyloP100: 4.65
Variant links:
Genes affected
DCTN1 (HGNC:2711): (dynactin subunit 1) This gene encodes the largest subunit of dynactin, a macromolecular complex consisting of 10 subunits ranging in size from 22 to 150 kD. Dynactin binds to both microtubules and cytoplasmic dynein. Dynactin is involved in a diverse array of cellular functions, including ER-to-Golgi transport, the centripetal movement of lysosomes and endosomes, spindle formation, chromosome movement, nuclear positioning, and axonogenesis. This subunit interacts with dynein intermediate chain by its domains directly binding to dynein and binds to microtubules via a highly conserved glycine-rich cytoskeleton-associated protein (CAP-Gly) domain in its N-terminus. Alternative splicing of this gene results in multiple transcript variants encoding distinct isoforms. Mutations in this gene cause distal hereditary motor neuronopathy type VIIB (HMN7B) which is also known as distal spinal and bulbar muscular atrophy (dSBMA). [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007178724).
BP6
Variant 2-74361590-G-A is Benign according to our data. Variant chr2-74361590-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 8402.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-74361590-G-A is described in Lovd as [Pathogenic]. Variant chr2-74361590-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00282 (430/152224) while in subpopulation NFE AF= 0.00491 (334/68008). AF 95% confidence interval is 0.00448. There are 2 homozygotes in gnomad4. There are 214 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 430 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DCTN1NM_004082.5 linkuse as main transcriptc.3746C>T p.Thr1249Ile missense_variant 32/32 ENST00000628224.3 NP_004073.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DCTN1ENST00000628224.3 linkuse as main transcriptc.3746C>T p.Thr1249Ile missense_variant 32/325 NM_004082.5 ENSP00000487279 A1Q14203-1

Frequencies

GnomAD3 genomes
AF:
0.00283
AC:
430
AN:
152106
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000845
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00282
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00491
Gnomad OTH
AF:
0.00335
GnomAD3 exomes
AF:
0.00288
AC:
725
AN:
251428
Hom.:
3
AF XY:
0.00297
AC XY:
403
AN XY:
135888
show subpopulations
Gnomad AFR exome
AF:
0.000677
Gnomad AMR exome
AF:
0.000925
Gnomad ASJ exome
AF:
0.00159
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00261
Gnomad FIN exome
AF:
0.000508
Gnomad NFE exome
AF:
0.00496
Gnomad OTH exome
AF:
0.00179
GnomAD4 exome
AF:
0.00492
AC:
7197
AN:
1461886
Hom.:
29
Cov.:
31
AF XY:
0.00484
AC XY:
3522
AN XY:
727248
show subpopulations
Gnomad4 AFR exome
AF:
0.000687
Gnomad4 AMR exome
AF:
0.00110
Gnomad4 ASJ exome
AF:
0.00126
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00212
Gnomad4 FIN exome
AF:
0.000487
Gnomad4 NFE exome
AF:
0.00600
Gnomad4 OTH exome
AF:
0.00354
GnomAD4 genome
AF:
0.00282
AC:
430
AN:
152224
Hom.:
2
Cov.:
32
AF XY:
0.00287
AC XY:
214
AN XY:
74438
show subpopulations
Gnomad4 AFR
AF:
0.000843
Gnomad4 AMR
AF:
0.00281
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00104
Gnomad4 FIN
AF:
0.000471
Gnomad4 NFE
AF:
0.00491
Gnomad4 OTH
AF:
0.00332
Alfa
AF:
0.00421
Hom.:
3
Bravo
AF:
0.00294
TwinsUK
AF:
0.00485
AC:
18
ALSPAC
AF:
0.00597
AC:
23
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00453
AC:
39
ExAC
AF:
0.00304
AC:
369
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:11Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:6
Benign, criteria provided, single submitterclinical testingGeneDxAug 15, 2019This variant is associated with the following publications: (PMID: 28430856, 27132499, 15326253, 23143281) -
Benign, no assertion criteria providedliterature onlyNorthcott Neuroscience Laboratory, ANZAC Research Institute-- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesOct 16, 2023- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsMay 03, 2018- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024DCTN1: BS2 -
Perry syndrome Uncertain:1Benign:1
Uncertain significance, no assertion criteria providedliterature onlyInherited Neuropathy Consortium Ii, University Of MiamiJan 06, 2016- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaMar 06, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsJun 02, 2020This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Neuronopathy, distal hereditary motor, type 7B Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaMar 06, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Neuronopathy, distal hereditary motor, type 7B;C1862939:Amyotrophic lateral sclerosis type 1;C1868594:Perry syndrome Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Amyotrophic lateral sclerosis type 1 Benign:1
Benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Amyotrophic lateral sclerosis, susceptibility to Other:1
risk factor, no assertion criteria providedliterature onlyOMIMJun 09, 2009- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Uncertain
0.015
T
BayesDel_noAF
Pathogenic
0.25
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.13
T;.;T;.;.;.;T;.
Eigen
Benign
-0.029
Eigen_PC
Benign
0.17
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.82
T;T;T;T;T;T;.;T
M_CAP
Benign
0.075
D
MetaRNN
Benign
0.0072
T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.57
T
MutationAssessor
Benign
1.4
L;.;.;.;.;.;.;.
MutationTaster
Benign
1.0
D;D;D;D;D;D;D
PrimateAI
Uncertain
0.61
T
PROVEAN
Benign
-0.82
N;N;.;.;N;N;N;N
REVEL
Uncertain
0.38
Sift
Benign
0.033
D;D;.;.;D;D;D;D
Sift4G
Benign
0.13
T;T;T;T;T;T;T;T
Polyphen
0.27
B;.;.;B;.;.;.;.
Vest4
0.68
MVP
0.68
MPC
0.12
ClinPred
0.0099
T
GERP RS
5.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.078
gMVP
0.54

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs72466496; hg19: chr2-74588717; API